Skip to content

Valiant Navion™ VNMF4343C62TU (UDI 00763000100742)Recalls & reported problems

Medtronic, Inc. · STENT GRAFT VNMF4343C62TU VAL NAV FF · Class 3 · Implant

All models of Valiant Navion (137)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
2
Deaths reported
1
Injuries reported
1
Recalls naming it
1

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00763000100742), received between Oct 3, 2023 and Oct 21, 2024 — classified as 1 death, 1 injury.

The most frequently reported specific device problem is “Leak/Splash” (1 report).

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. Feb 12, 2021Class IOpen, Classified

    Due to the presence of type IIIb endoleaks, stent fractures, and stent ring enlargement.

    Z-1201-2021 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Leak/Splash1

Patient problems

  • Aneurysm2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 21, 2024Leak/Splash; Leak/Splash

    THREE VALIANT NAVION STENT GRAFTS WERE IMPLANTED DURING AN ENDOVASCULAR TREATMENT OF A TAA. IT WAS REPORTED THAT CT TAKEN AT 40 MONTHS POST INDEX PROCEDURE DEMONSTRATED AORTIC ENLARGEMENT. THE ANEURYSM DIAMETER MEASURED 69 X 85MM COMPARED TO PRIOR MEASUREMENT OF 69 X 69MM. CT FROM 41 MONTHS POS-INDEX PROCEDURE SHOWED INTERVAL ENLARGEMENT OF THE ANEURYSM SAC; NO DISCRETE ENDOLEAK IDENTIFIED, RAISING CONCERN FOR OCCULT ENDOLEAK. VASCULAR NOTES FROM 42 MONTHS POST-INDEX STATED THAT AORTIC ENLARGEMENT OCCURRED AND THE ANEURYSM DIAMETER MEASURED 89MM. A TYPE I ENDOLEAK WAS SUSPECTED FROM THE PROXIMAL NECK DUE TO TORTUOSITY OR FROM DISTAL TO PREVIOUS TUBE GRAFT ONLY. ANGIO FROM ONE DAY EARLIER IDENTIFIED A TYPE I ENDOLEAK ALONG PROXIMAL RIGHT ASPECT OF THE GRAFT; NO EVIDENCE OF TYPE II ENDOLEAK. 43 MONTHS POST-INDEX MULTIPLE ABDOMINAL AORTOGRAMS IDENTIFIED TYPE I ENDOLEAK PROXIMAL END OF GRAFT, UNABLE TO DETERMINE IF TYPE IA OR IB. DID NOT FULLY IDENTIFY FILLING OF THE ANEURYSM SAC. DID VISUALIZE LUMBAR AND MESENTERIC BRANCHES APPEARED TO BACK FLOW TOWARDS THE ANEURYSM SAC. 44 MONTHS POST-INDEX CONTRAST CT IDENTIFIED A FUSIFORM INFRARENAL AAA MEASURING 8.6X2.5CM IN CROSS SECTION. NO VISI

    Patient problems: Aneurysm

    MAUDE report 20491928 ↗
  • DeathOct 3, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A VALIANT NAVION STENT GRAFT WAS IMPLANTED DURING AN UNKNOWN ENDOVASCULAR PROCEDURE. IT WAS REPORTED THAT CORELAB REVIEW OF CT IMAGING DATED APPROXIMATELY 12 YEARS POST THE INDEX PROCEDURE SHOWED AORTIC ENLARGEMENT OF +15.2MM AND A MAXIMUM AORTIC DIAMETER OF 73.1MM AND CT IMAGING DATED (B)(6) 2022 SHOWED AORTIC ENLARGEMENT OF +11.8MM AND A MAXIMUM AORTIC DIAMETER OF 69.7MM. THE CTS WERE COMPARED TO IMAGING DATED (B)(6) 2020. ALL OF THE IMAGING WAS NON-EVALUABLE FOR FRACTURE, STENT RING ENLARGEMENT AND STENT RING MIGRATION. NO ENDOLEAKS WERE OBSERVED. NO CAUSE WAS PROVIDED. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT IS EXPIRED. NO INFORMATION OF THE CAUSE OR DATE OF DEATH HAS BEEN PROVIDED.

    Patient problems: Aneurysm

    MAUDE report 17859542 ↗

Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices

All SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page